Follow-up screening | Diabetes women (N = 124) | Treatment women (N = 229) | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
Control + N (%) | Control – N (%) | Missing N (%)* | p | Control + N | Control – N | p | Control + N | Control – N | p | |
General practitioner (N = 2171) | ||||||||||
Control 1: Within 3 months after birth | 1744 (80.5) | 423 (19.5) | 41 (0.2) | <0.001 | 112 | 12 | 0.0045 | 205 | 24 | 0.0002 |
Control 2: 3 months to 2 years | 852 (47.3) | 950 (52.7) | 369 (17.0) | 0.0210 | 108 | 16 | <0.0001 | 188 | 37 | <0.0001 |
Control 3: 2 years to 4 years | 526 (29.1) | 1281 (70.9) | 364 (16.8) | <0.001 | 94 | 27 | <0.0001 | 152 | 62 | <0.0001 |
Control 4: 4 years to 6 years | 333 (17.7) | 1551 (82.3) | 287 (12.8) | <0.001 | 75 | 37 | <0.0001 | 116 | 89 | <0.0001 |
Biochemical unit** (N = 1218) | ||||||||||
Control 1: Within 6 months after birth | 111 (10.2) | 979 (89.8) | 128 (10.5) | <0.001 | 113 | 10 | 0.4932 | 181 | 40 | <0.0001 |
Control 2: 6 moths to 2.4 years | 69 (6.4) | 1013 (93.6) | 136 (11.2) | <0.001 | 113 | 10 | 0.8829 | 184 | 36 | <0.0001 |
Control 3: 2.4 years to 4.5 years | 29 (2.5) | 1116 (97.5) | 73 (6.0) | <0.001 | 113 | 9 | 0.3085 | 192 | 28 | <0.0001 |
Control 4: 4.5 years to 8.2 years | 6 (0.5) | 1190 (99.5) | 22 (1.8) | <0.001 | 115 | 5 | 0.7766 | 198 | 22 | <0.0001 |